49. A SYSTEMATIC REVIEW OF HEALTH ECONOMIC EVALUATIONS OF PD-(L)1 INHIBITORS FOR FIRST-LINE TREATMENT AMONG PATIENTS WITH HIGH PD-L1 EXPRESSION NON-SMALL CELL LUNG CANCER. (2024). Vietnam Journal of Community Medicine, 65(Tiếng Anh). https://doi.org/10.52163/yhc.v65i13.1891